Neuroleptics in acute mania: Apharmacoepidemiologic study

Annals of Pharmacotherapy

Volumn 30, Issue 12, 1996, Pages 1396-1398

  Chou, James C Y ^a,b   Zito, Julie Magno ^c   Vitrai, Jozsef ^d   Craig, Thomas J ^e   Allingham, Baerbel H ^f   Czobor, Pal ^f  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Nathan Kline Institute for Psychiatric Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; DIAZEPAM; FLUPHENAZINE; HALOPERIDOL; LITHIUM; LORAZEPAM; LOXAPINE; MESORIDAZINE; NEUROLEPTIC AGENT; PERPHENAZINE; TEMAZEPAM; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; VALPROIC ACID;

ACUTE DISEASE; ADULT; ARTICLE; DRUG CHOICE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; MALE; PHARMACOEPIDEMIOLOGY;

EID: 0030448815     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001206     Document Type: Article

References (14)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(suppl 12):1-36.
2. Dunner DC, Clayton PJ. Drug treatment of bipolar disorder. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1077-83.
3. Prien RF, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990;26:409-27.
4. Semyak MJ, Woods SW Chronic neuroleptic use in manic-depressive illness. Psychopharmacol Bull 1993;29:375-81.
5. Zito JM, Craig TJ. Pharmacoepidemiology of psychiatric disorders. In: Hartzema AG, Porta MS, Tilson HH, eds. Pharmacoepidemiology: an introduction. Cincinnati: Harvey Whitney Books, 1991:270-88.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised. Washington, DC: American Psychiatric Association, 1987.
7. Davis JM, Barter JT, Kane JM. Antipsychotic drugs. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry. 5th ed. Baltimore: Williams and Wilkins, 1989:1591-626.
8. Zito JM, Craig TJ, Wanderling J, Siegel C. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients. Am J Psychiatry 1987;144:778-82.
9. Chou JC. Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991;11:3-21.
10. Semyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE, Woods SW. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-5.
11. Arana GW, Omsteen ML, Kanter F, Friedman HL, Greenblatt DJ, Shader RI. The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psychopharmacol Bull 1986;22:77-87.
12. Busch FN, Miller FT, Weiden PJ. A comparison of two adjunctive treatment strategies in acute mania. J Clin Psychiatry 1989;50:453-5.
13. Baldessarini RJ, Kando JC, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry 1995;152:1038-44.
14. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.